Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Leukemia
|
February 19, 2013
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy
T Scullen, L Santo, S Vallet, et al.
Leukemia
|
September 11, 2009
The use of novel agents in the treatment of relapsed and refractory multiple myeloma
J P Laubach, A Mahindra, C S Mitsiades, et al.
Bone Marrow Transplantation
|
April 5, 2011
Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia
A Mahindra, B J Bolwell, L Rybicki, et al.
Bone Marrow Transplantation
|
September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis
G N Mannis, A C Logan, A D Leavitt, et al.
Leukemia
|
November 2, 2011
Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research
A Mahindra, M E Kalaycio, J Vela-Ojeda, et al.
Bone Marrow Transplantation
|
September 19, 2017
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis
A Mahindra, P Hari, R Fraser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Leukemia
|
December 30, 2015
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
J Laubach, L Garderet, A Mahindra, et al.
Leukemia
|
January 5, 2013
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
C Fernández de Larrea, R A Kyle, B G M Durie, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Leukemia
|
February 19, 2013
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy
T Scullen, L Santo, S Vallet, et al.
Leukemia
|
September 11, 2009
The use of novel agents in the treatment of relapsed and refractory multiple myeloma
J P Laubach, A Mahindra, C S Mitsiades, et al.
Bone Marrow Transplantation
|
April 5, 2011
Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia
A Mahindra, B J Bolwell, L Rybicki, et al.
Bone Marrow Transplantation
|
September 23, 2014
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis
G N Mannis, A C Logan, A D Leavitt, et al.
Leukemia
|
November 2, 2011
Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research
A Mahindra, M E Kalaycio, J Vela-Ojeda, et al.
Bone Marrow Transplantation
|
September 19, 2017
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis
A Mahindra, P Hari, R Fraser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensus
P Musto, K C Anderson, M Attal, et al.
Leukemia
|
December 30, 2015
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
J Laubach, L Garderet, A Mahindra, et al.
Leukemia
|
January 5, 2013
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
C Fernández de Larrea, R A Kyle, B G M Durie, et al.
Page
of 1